CGEN

Compugen Ltd.

0.75 USD

Last updated Dec 4, 19:24 UTC

Yesterday HIGH

$0.76

Yesterday LOW

$0.66

52w HIGH

$1.49

52w LOW

$0.53

EPS

-0.11

PE

-6.82

Next Earnings

Feb 26, 2024

Overview News Government Trades

Compugen Ltd. stock is up 1.35% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.83% of the previous 23 December’s closed higher than November.

Compugen Ltd. researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors. COM902, a therapeutic antibody targeting TIGIT, and AZD2936, a novel anti-TIGIT/PD-1 bispecific antibody, are in clinical study in patients with advanced or metastatic non-small cell lung cancer.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Holon, Israel

Website

cgen.com

richadhand@benzinga.com

Tue May 16, 2023

Oppenheimer Maintains Outperform on Compugen, Lowers Price Target to $7

Oppenheimer analyst Mark Breidenbach maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $8 to $7.
Benzinga Insights

Mon May 15, 2023

Compugen: Q1 Earnings Insights
Benzinga Newsdesk

Mon May 15, 2023

Compugen Q1 EPS $(0.11) Beats $(0.12) Estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is unchanged from the same period last year.
Benzinga Insights

Mon May 15, 2023

Earnings Scheduled For May 15, 2023

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
Chris Katje

Sat Mar 11, 2023

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company’s Silicon Valley Bank.
Benzinga Newsdesk

Fri Mar 10, 2023

Compugen Says Co Has ~1.3% Of Cash With SVB

-SEC Filing
Benzinga Newsdesk

Mon Mar 6, 2023

Compugen Doses First Patient In Triple Combination COM701, COM902 And Pembrolizumab MSS CRC Proof-Of-Concept Study
richadhand@benzinga.com

Tue Feb 28, 2023

Oppenheimer Reiterates Outperform on Compugen, Maintains $8 Price Target

Oppenheimer analyst Mark Breidenbach reiterates Compugen (NASDAQ:CGEN) with a Outperform and maintains $8 price target.
Benzinga Newsdesk

Mon Feb 27, 2023

Compugen Q4 EPS $(0.04) Beats $(0.14) Estimate, Sales $7.50M; Approximately $83.7M In Cash Expected To Fund Operations At Least Through End Of 2024

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.14) by 71.43 percent. This is a 60 percent increase over losses of $(0.10) per share from the same
Benzinga Insights

Mon Feb 27, 2023

Earnings Scheduled For February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.